MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
about
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and ApoptosisSubclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and PerspectivesLooking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium SurvivalCirculating miR-30d Predicts Survival in Patients with Acute Heart Failure.Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion.Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery FunctionEndothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis.Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2DThe anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlying signaling mechanisms in a rat model of diabetes mellitus.Circulating microRNAs in patients with ST-elevation myocardial infarction.Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma.Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathyPosttranscriptional regulation of FOXO expression: microRNAs and beyond.An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).miR-223 contributes to the AGE-promoted apoptosis via down-regulating insulin-like growth factor 1 receptor in osteoblasts.Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse.NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats.MicroRNA as a Therapeutic Target in Cardiac Remodeling.Regulating MicroRNA Expression: At the Heart of Diabetes Mellitus and the Mitochondrion.Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective.MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway.Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis.Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1β.Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3.Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus.Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.Low-intensity pulsed ultrasound promotes Schwann cell viability and proliferation via the GSK-3β/β-catenin signaling pathway.Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathyMiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
P2860
Q26746965-10B13AD2-96AA-4E07-8E88-6AA65E71E30DQ26771750-5AD0699A-51BE-4DE1-BAE3-7BE813EE52A6Q26778539-773437AA-75E6-4359-B184-599EDCCD17EBQ33902036-979AF78C-A63B-48EB-80F7-37EE1B77FC02Q35591738-CB0E110E-2078-49B0-91D5-0D86A5E48B6DQ35761959-2BABC5B5-EE06-46D1-A572-A6C83F89D789Q36145584-9BB1889B-96AE-4B0F-BA75-7FBFBBE103B3Q36500050-8393E572-0124-4AEF-9488-8E244ED50EFCQ37323904-8ED05087-5AFF-4966-83EA-8001C4C433D5Q37672902-BF35374D-11ED-46AC-8391-98B9A0A0E66BQ37700697-B3403AA0-2FDF-4C37-82EA-25D296CEE925Q37708998-529C8C1F-03C5-41B4-92B1-3E8C6E331744Q37745344-740789BF-930C-4B43-9018-36C7A59FC82AQ38752093-80539E4B-80B9-4E71-8A53-25AA4FE02759Q38771776-138A02B1-FCAC-40C7-B55A-A67500E2D5DDQ38792762-44423037-C679-4B4D-A291-D6F39E4D8CA3Q39201286-5BF9E28A-5270-467D-9B73-7C223FB0970CQ42258755-E8981DA4-BB57-4B9F-900A-32AAE0C1127BQ43372985-FB50CA5E-DFDA-414B-AAB1-730044D25AA2Q44732086-293856E6-5964-4B4C-A039-977317117E71Q45069455-C313171A-C32E-4BF0-B431-B06CCD39E58DQ46946033-88559698-3D41-433C-85EC-4E1C9E7DB96CQ47141425-59968E24-45F0-4F42-8691-C710088AF97FQ48102194-62D040B3-99F6-400F-BBAC-526E07322F12Q48200760-86AAB82A-BDB7-40E4-AD66-CF8642CC738DQ50026322-31238761-FF90-4BA8-9353-724BCE999EB3Q50130043-97B4EF4F-B15B-4267-8539-40ACEBC06223Q50327592-5C960ABE-6557-4FF2-BC67-B9420FF991CDQ51288592-BC5AB26A-A9C4-40C3-97CA-F86680A37264Q52642353-C6C5A379-DD6C-41DC-A12F-BD9F93D625E8Q53095027-88166668-0BB1-4A6E-ACED-F699B7ABE9C6Q55273552-102B19D5-AF8C-443B-9CE2-78903256383DQ58700479-84081C3B-FD3D-48D2-8D93-AF02D4089749Q58765609-C4E01156-5DC7-4A4B-89F9-7B65715F4C77
P2860
MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@ast
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@en
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@nl
type
label
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@ast
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@en
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@nl
prefLabel
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@ast
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@en
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@nl
P2093
P2860
P356
P1476
MicroRNA-30d regulates cardiom ...... o3a in diabetic cardiomyopathy
@en
P2093
P2860
P2888
P356
10.1038/CDDIS.2014.430
P50
P577
2014-10-23T00:00:00Z
P5875
P6179
1011871512